240 related articles for article (PubMed ID: 24860425)
1. Insights gained from gene therapy in animal models of retGC1 deficiency.
Boye SE
Front Mol Neurosci; 2014; 7():43. PubMed ID: 24860425
[TBL] [Abstract][Full Text] [Related]
2. A Mini-review: Animal Models of GUCY2D Leber Congenital Amaurosis (LCA1).
Boye SE
Adv Exp Med Biol; 2016; 854():253-8. PubMed ID: 26427419
[TBL] [Abstract][Full Text] [Related]
3. Determining consequences of retinal membrane guanylyl cyclase (RetGC1) deficiency in human Leber congenital amaurosis en route to therapy: residual cone-photoreceptor vision correlates with biochemical properties of the mutants.
Jacobson SG; Cideciyan AV; Peshenko IV; Sumaroka A; Olshevskaya EV; Cao L; Schwartz SB; Roman AJ; Olivares MB; Sadigh S; Yau KW; Heon E; Stone EM; Dizhoor AM
Hum Mol Genet; 2013 Jan; 22(1):168-83. PubMed ID: 23035049
[TBL] [Abstract][Full Text] [Related]
4. AAV-mediated gene therapy in the guanylate cyclase (RetGC1/RetGC2) double knockout mouse model of Leber congenital amaurosis.
Boye SL; Peshenko IV; Huang WC; Min SH; McDoom I; Kay CN; Liu X; Dyka FM; Foster TC; Umino Y; Karan S; Jacobson SG; Baehr W; Dizhoor A; Hauswirth WW; Boye SE
Hum Gene Ther; 2013 Feb; 24(2):189-202. PubMed ID: 23210611
[TBL] [Abstract][Full Text] [Related]
5. Gene Therapy Fully Restores Vision to the All-Cone Nrl(-/-) Gucy2e(-/-) Mouse Model of Leber Congenital Amaurosis-1.
Boye SL; Peterson JJ; Choudhury S; Min SH; Ruan Q; McCullough KT; Zhang Z; Olshevskaya EV; Peshenko IV; Hauswirth WW; Ding XQ; Dizhoor AM; Boye SE
Hum Gene Ther; 2015 Sep; 26(9):575-92. PubMed ID: 26247368
[TBL] [Abstract][Full Text] [Related]
6. Leber congenital amaurosis caused by mutations in GUCY2D.
Boye SE
Cold Spring Harb Perspect Med; 2014 Sep; 5(1):a017350. PubMed ID: 25256176
[TBL] [Abstract][Full Text] [Related]
7.
Peshenko IV; Olshevskaya EV; Dizhoor AM
J Biol Chem; 2020 Dec; 295(52):18301-18315. PubMed ID: 33109612
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the role of retinal membrane guanylyl cyclase 1 (RetGC1) domains in binding guanylyl cyclase-activating proteins (GCAPs).
Peshenko IV; Olshevskaya EV; Dizhoor AM
J Biol Chem; 2015 Mar; 290(11):6913-24. PubMed ID: 25616661
[TBL] [Abstract][Full Text] [Related]
9. GUCY2D Cone-Rod Dystrophy-6 Is a "Phototransduction Disease" Triggered by Abnormal Calcium Feedback on Retinal Membrane Guanylyl Cyclase 1.
Sato S; Peshenko IV; Olshevskaya EV; Kefalov VJ; Dizhoor AM
J Neurosci; 2018 Mar; 38(12):2990-3000. PubMed ID: 29440533
[TBL] [Abstract][Full Text] [Related]
10. Retinal degeneration-3 protein attenuates photoreceptor degeneration in transgenic mice expressing dominant mutation of human retinal guanylyl cyclase.
Peshenko IV; Olshevskaya EV; Dizhoor AM
J Biol Chem; 2021 Oct; 297(4):101201. PubMed ID: 34537244
[TBL] [Abstract][Full Text] [Related]
11. Guanylate cyclase-activating protein 2 contributes to phototransduction and light adaptation in mouse cone photoreceptors.
Vinberg F; Peshenko IV; Chen J; Dizhoor AM; Kefalov VJ
J Biol Chem; 2018 May; 293(19):7457-7465. PubMed ID: 29549122
[TBL] [Abstract][Full Text] [Related]
12. Functional study of two biochemically unusual mutations in
Boye SL; Olshevskaya EV; Peshenko IV; McCullough KT; Boye SE; Dizhoor AM
Mol Vis; 2016; 22():1342-1351. PubMed ID: 27881908
[TBL] [Abstract][Full Text] [Related]
13. Functional and behavioral restoration of vision by gene therapy in the guanylate cyclase-1 (GC1) knockout mouse.
Boye SE; Boye SL; Pang J; Ryals R; Everhart D; Umino Y; Neeley AW; Besharse J; Barlow R; Hauswirth WW
PLoS One; 2010 Jun; 5(6):e11306. PubMed ID: 20593011
[TBL] [Abstract][Full Text] [Related]
14. Retinal guanylyl cyclase isozyme 1 is the preferential in vivo target for constitutively active GCAP1 mutants causing congenital degeneration of photoreceptors.
Olshevskaya EV; Peshenko IV; Savchenko AB; Dizhoor AM
J Neurosci; 2012 May; 32(21):7208-17. PubMed ID: 22623665
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of retinal membrane guanylate cyclase regulation by GCAP1 and RD3.
Ames JB
Front Mol Neurosci; 2022; 15():988142. PubMed ID: 36157073
[TBL] [Abstract][Full Text] [Related]
16. Preclinical studies in support of phase I/II clinical trials to treat
Boye SL; O'Riordan C; Morris J; Lukason M; Compton D; Baek R; Elmore DM; Peterson JJ; Fajardo D; McCullough KT; Scaria A; McVie-Wylie A; Boye SE
Mol Ther Methods Clin Dev; 2023 Mar; 28():129-145. PubMed ID: 36654798
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic relay mechanism stimulates cyclic GMP synthesis in rod photoresponse: biochemical and physiological study in guanylyl cyclase activating protein 1 knockout mice.
Makino CL; Wen XH; Olshevskaya EV; Peshenko IV; Savchenko AB; Dizhoor AM
PLoS One; 2012; 7(10):e47637. PubMed ID: 23082185
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral expression of retinal guanylate cyclase-1 (RetGC1) restores vision in an avian model of childhood blindness.
Williams ML; Coleman JE; Haire SE; Aleman TS; Cideciyan AV; Sokal I; Palczewski K; Jacobson SG; Semple-Rowland SL
PLoS Med; 2006 Jun; 3(6):e201. PubMed ID: 16700630
[TBL] [Abstract][Full Text] [Related]
19. Guanylate cyclases and associated activator proteins in retinal disease.
Hunt DM; Buch P; Michaelides M
Mol Cell Biochem; 2010 Jan; 334(1-2):157-68. PubMed ID: 19941038
[TBL] [Abstract][Full Text] [Related]
20. Impaired association of retinal degeneration-3 with guanylate cyclase-1 and guanylate cyclase-activating protein-1 leads to leber congenital amaurosis-1.
Zulliger R; Naash MI; Rajala RV; Molday RS; Azadi S
J Biol Chem; 2015 Feb; 290(6):3488-99. PubMed ID: 25477517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
